Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
2.300
-0.230 (-9.37%)
Dec 3, 2024, 12:19 PM EST - Market open
Impact BioMedical Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
26.46M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionIBO News
- 7 weeks ago - Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease - GlobeNewsWire
- 2 months ago - Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates - GlobeNewsWire
- 2 months ago - Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue - GlobeNewsWire
- 2 months ago - Impact BioMedical Inc. Announces the Closing of its Initial Public Offering - GlobeNewsWire
- 2 months ago - Impact BioMedical Inc. Announces Pricing of Initial Public Offering - GlobeNewsWire
- 1 year ago - Impact BioMedical IPO Registration Document (S-1) - SEC